6932Mercury Biopharmaceutical Corporation6932 info
$0.48info-1.59%24h
Global rank17311
Market cap$200.94M
Change 7d-
YTD Performance-17.38%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Mercury Biopharmaceutical Corporation (6932) Stock Overview

    Mercury Biopharmaceutical Corporation engages in the development of drugs for unmet needs in Taiwan. The company develops StackDose platform, a drug development platform to produce new dosage forms with precise time-controlled dissolution, precise site absorption, and various dosage adjustments to enhance the bio-availability of active pharmaceutical ingredients to reduce the dosage of drugs and its side effects. It develops drugs for treating erectile dysfunction, pulmonary hypertension, sleep disorder, benign prostatic hyperplasia, angina pectoris, migraine, anti-hypertension, and analgesic. The company was founded in 2019 and is based in New Taipei City, Taiwan.

    6932 Stock Information

    Symbol
    6932
    Address
    15th FloorNew Taipei City, Taiwan
    Founded
    -
    Trading hours
    -
    Website
    https://merdury.com
    Country
    🇹🇼 Taiwan
    Phone Number
    886 2 8221 2020

    Mercury Biopharmaceutical Corporation (6932) Price Chart

    -
    Value:-

    Mercury Biopharmaceutical Corporation Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.48306762008685833
    N/A
    Market Cap
    $200.94M
    N/A
    Shares Outstanding
    415.96M
    N/A
    Employees
    16.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org